Beyond Diabetes and Obesity: Researchers are studying numerous additional indications that could expand the use of these medications beyond diabetes and obesity
FCPS: With the removal of HealthKeepers effective March 1, 2026, will we still experience provider participation issues
The decision between long-term and short-term use should be individualized, considering factors such as degree of obesity, presence of complications, treatment response, side effect profile, cost and insurance coverage, and patient preferences and goals
Learn as much as you can and take the information to your doctor with suggestions and perhaps the two of you can work together
Your GP can coordinate appropriate investigations and refer to specialist services (hepatology, nephrology, urology, or endocrinology) when indicated